--GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link-March 2024-www.financetom.com

--GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link

May 23, 2024 11:15 AM

01:57 PM EDT, 05/23/2024 (MT Newswires) --

Price: 45.06, Change: -0.73, Percent Change: -1.58

Previous page： Chinese cosmetics maker Yatsen's Q3 net loss narrows Next page： Bitcoin falls nearly 2% to $93,684

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Chinese cosmetics maker Yatsen's Q3 net loss narrows

Nov 17, 2025

Overview * Yatsen Q3 2025 revenue rose 47.5% yr/yr to RMB998.4 mln * Net loss for Q3 2025 narrowed by 41.9% to RMB70.4 mln * Gross margin improved to 78.2% from 75.9% yr/yr Outlook * Yatsen expects Q4 2025 revenue between RMB1.32 bln and RMB1.49 bln * Company focuses on brand and product innovation for sustainable growth * Yatsen (...

Bitcoin falls nearly 2% to $93,684

Nov 17, 2025

(Reuters) -Bitcoin, the world's largest cryptocurrency by market value, was down by 1.59% at $93,684 at 4:21 p.m. ET (2121 GMT) on Sunday. ...

Emirates orders 65 more 777X as Boeing studies larger jet

Nov 17, 2025

DUBAI (Reuters) -Dubai-based airline Emirates said on Monday it was ordering another 65 Boeing 777-9 jets, cementing its position as the world's biggest buyer of wide-body jets as the U.S. planemaker agreed to carry out a feasibility study for a larger version. Emirates valued the deal for Boeing's ( BA ) largest in-production jet at $38 billion, though analysts say...

XPeng's Q3 Adjusted Loss Narrows, Revenue Rises; Shares Fall Pre-Bell

Nov 17, 2025

04:33 AM EST, 11/17/2025 (MT Newswires) -- XPeng ( XPEV ) reported Monday a Q3 adjusted net loss of 0.16 Chinese renminbi ($0.02) per diluted American depositary share, narrowing from an adjusted loss of 1.62 renminbi a year earlier. Four analysts polled by FactSet expected a loss of 0.49 renminbi. Revenue for the quarter ended Sept. 30 was 20.38 billion...